Heat/NN
shock/NN
induces/VBZ
HIV-1/NN
replication/NN
in/IN
chronically/RB
infected/JJ
promyelocyte/JJ
cell/NN
line/NN
OM10.1/NN
./.

A/DT
long/JJ
period/NN
of/IN
clinical/JJ
latency/NN
before/IN
development/NN
of/IN
symptoms/NNS
is/VBZ
characteristic/JJ
of/IN
human/JJ
immunodeficiency/NN
virus/NN
type/NN
1/CD
(/(
HIV-1/NN
)/)
infection/NN
./.
=====
OM10.1/NN
,/,
a/DT
promyelocyte/JJ
cell/NN
line/NN
latently/RB
infected/VBN
with/IN
HIV-1/NN
,/,
has/VBZ
been/VBN
developed/VBN
as/IN
a/DT
model/NN
for/IN
studying/VBG
the/DT
mechanism/NN
of/IN
viral/JJ
latency/NN
and/CC
the/DT
activation/NN
of/IN
virus/NN
expression/NN
./.
=====
We/PRP
found/VBD
that/IN
this/DT
latently/RB
infected/JJ
cell/NN
line/NN
with/IN
heat/NN
shock/NN
at/IN
42/CD
degrees/NNS
C/NN
for/IN
2/CD
h/NN
resulted/VBD
in/IN
a/DT
high/JJ
level/NN
of/IN
HIV-1/NN
production/NN
without/IN
addition/NN
of/IN
any/DT
cytokines/NNS
./.
=====
The/DT
mechanism/NN
of/IN
activation/NN
was/VBD
analyzed/VBN
by/IN
using/VBG
anti-TNF-alpha/JJ
antibody/NN
and/CC
various/JJ
inhibitors/NNS
./.
=====
Although/IN
the/DT
TNF-alpha/NN
level/NN
in/IN
culture/NN
supernatants/NNS
was/VBD
below/IN
the/DT
sensitivity/NN
of/IN
an/DT
ELISA/NN
assay/NN
system/NN
,/,
addition/NN
of/IN
anti-TNF-alpha/JJ
antibody/NN
in/IN
culture/NN
medium/NN
could/MD
partially/RB
suppress/VB
the/DT
heat/NN
shock/NN
induced/JJ
HIV-1/NN
production/NN
./.
=====
Staurosporine/NN
(/(
PKC/NN
inhibitor/NN
)/)
,/,
pentoxifylline/NN
(/(
NF-kappa/NN
B/NN
inhibitor/NN
)/)
,/,
and/CC
Ro5-3335/NN
(/(
HIV-1/NN
Tat/NN
inhibitor/NN
)/)
also/RB
inhibited/VBD
significantly/RB
the/DT
heat/NN
shock/NN
induced/JJ
virus/NN
activation/NN
./.
=====
In/IN
particular/JJ
,/,
staurosporine/NN
achieved/VBD
approximately/RB
90/CD
%/NN
inhibition/NN
of/IN
the/DT
HIV-1/NN
antigen/NN
expression/NN
in/IN
heat/NN
shock-treated/JJ
OM10.1/NN
at/IN
a/DT
non-toxic/JJ
concentration/NN
./.
=====
Although/IN
the/DT
mechanism/NN
of/IN
HIV-1/NN
activation/NN
with/IN
heat/NN
shock/NN
has/VBZ
not/RB
been/VBN
fully/RB
elucidated/VBN
yet/RB
,/,
it/PRP
is/VBZ
presumed/VBN
PKC/NN
plays/VBZ
an/DT
important/JJ
role/NN
in/IN
HIV-1/NN
activation/NN
./.
=====
Thus/RB
,/,
the/DT
present/JJ
observations/NNS
will/MD
provide/VB
a/DT
further/JJ
insight/NN
into/IN
the/DT
pathogenesis/NN
of/IN
HIV-1/NN
infections/NNS
./.